Minor
ADVANCE · ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment
Trial sites expanded: 6 → 9 locations
BillionToOne Inc.Not specified NCT07643896 Registry history of NCT07643896 on ClinicalTrials.gov (opens the registry)
Updated